Articles

June 29, 2026 · Pharmaceuticals

EU-GMP Annex 15 Revision: What the Move Toward December 2026 Means for API Manufacturers

The EU-GMP Annex 15 revision will make qualification and validation mandatory for chemical and biological active substance (API) manufacturers, not just finished-product sites. A joint EMA and PIC/S concept paper set the direction, consultation closed in April 2026, and the final text is targeted for publication by December 2026. Here is what the timeline means and how API sites should prepare.

#EU-GMP

By Mussarat Fatima

June 29, 2026 · Pharmaceuticals

FDA's New Wave of Compounded GLP-1 Warning Letters (2026)

The FDA issued 25 warning letters in June 2026 over false or misleading promotion of compounded GLP-1 products. Here is what telehealth, pharmaceutical, and natural health product companies must fix, in the United States and Canada, to stay compliant.

#GLP-1

By Mussarat Fatima

June 27, 2026 · Food and Beverages

CFIA's 2026 Food Fraud Report: What 150,000 kg of Seized Food Means for Your Compliance Program

On June 25, 2026, the CFIA released its Food Fraud Annual Report 2024 to 2025: 886 authenticity samples tested and more than 150,000 kg of misrepresented food kept off the market. Olive oil had the lowest authenticity compliance and imported honey drove most of the seized volume. Here is what the findings mean for food manufacturers, importers and co-packers, and how to build food fraud controls into your compliance program.

#Food Fraud

By Mussarat Fatima

June 27, 2026 · Pharmaceuticals

Nitrosamine Impurities in 2026: Health Canada's Updated Guidance, New AI Limits and What MAHs Must Do Now

Health Canada's revised nitrosamine guidance changes the notification trigger and updates Acceptable Intake limits. Here is what pharmaceutical MAHs must do now to stay compliant.

#Nitrosamine Impurities

By Mussarat Fatima

June 24, 2026 · Food and Beverages

Supplemented Foods Compliance in Canada: Labels, Cautionary Statements and the Division 29 Checklist

Canada's supplemented foods transition period ended December 31, 2025. CFIA is now verifying Division 29 labels. Here is what a compliant label requires and where to start.

#Supplemented Foods

By Mussarat Fatima

June 23, 2026 · Pharmaceuticals

The ICH Q1 Stability Overhaul: What Changes for Your Stability Program in 2026

ICH Q1 is being rewritten. One consolidated guideline will replace Q1A-F and Q5C, extend stability testing to biologics and advanced therapies, and tie stability to the product lifecycle. Here is what changes for your stability program.

#Stability Testing

By Mussarat Fatima

June 22, 2026 · Regulatory Affairs

Health Canada's Low-Risk Drug Order: A Faster Path to Market for Sunscreens and OTC Products

Health Canada has proposed a Ministerial Order to exempt low-risk non-prescription drugs and sunscreens from the new-drug pathway. Here is what it covers, where the compliance risks sit, and how to comment by July 14, 2026.

#Non-prescription Drugs

By Mussarat Fatima

June 21, 2026 · Compliance

Texas Cannabis Licence: How to Apply Under the Expanded TCUP

Texas expanded its Compassionate Use Program in 2025 under HB 46, adding 12 new dispensing organization licences. Here is how the Texas cannabis licence works, who can apply, and what a competitive application requires.

#Cannabis

By Mussarat Fatima

June 20, 2026 · Compliance

NHP Compliance in Canada: Licensing, GMP and Labelling

A current guide to natural health product compliance in Canada, covering product and site licensing, GMP, Vanessa's Law enforcement, modernized labelling and cost recovery.

#Natural Health Products

By Mussarat Fatima

June 20, 2026 · Cultivation

Cannabis IPM in Canada: A Compliant Pest Control Guide

Integrated Pest Management protects cannabis crops without putting your licence at risk. This 2026 guide covers action thresholds, monitoring, prevention and controls, plus the Health Canada pesticide rules and mandatory testing every licensed producer must meet.

#Cannabis

By Mussarat Fatima

June 20, 2026 · Compliance

Labelling Compliance in Canada: 10 Ways to Prevent Errors

A practical, up-to-date guide to labelling compliance in Canada across food, cannabis and natural health products, with 10 ways to prevent costly label errors and recalls.

#Food Labelling

By Mussarat Fatima

June 20, 2026 · Cultivation

Why Sensory Evaluation Is Crucial for Cannabis Products

Sensory evaluation is a frontline quality control tool for cannabis. Learn how appearance, aroma and texture checks support Health Canada compliance, how they differ from lab testing, and how to build a defensible program.

#Cannabis

By Mussarat Fatima

June 20, 2026 · Medical Device

FDA QMSR and ISO 13485:2016: What Medical Device Makers Must Do Now

The FDA's Quality Management System Regulation replaced the QSR on February 2, 2026 and built 21 CFR Part 820 on ISO 13485:2016. Here is what changed, what records FDA can now inspect, and the steps device makers should take to stay compliant.

#FDA

By Mussarat Fatima

June 19, 2026 · Compliance

How Cannabis Licensing Consultants Streamline Compliance

How experienced cannabis licensing consultants help Canadian licence holders streamline Health Canada compliance, from licensing and SOPs to audits, CTLS reporting and QAP support.

#Cannabis

By Mussarat Fatima

June 19, 2026 · Compliance

How to Pass a Health Canada Cannabis Inspection: 6 Practical Steps

A practical, up to date guide to passing a Health Canada cannabis inspection, built around the latest 2025 to 2026 inspection data, the March 2025 rule changes, Good Production Practices, recordkeeping and the right way to handle CAPA.

#Cannabis

By Mussarat Fatima

June 19, 2026 · Regulatory Affairs

MDEL Phase II Amendments 2026: What Medical Device Importers and Distributors Must Do Before December 14

Health Canada's MDEL Phase II amendments (SOR/2026-110) take effect December 14, 2026. A practical guide to the foreign distributor exemption, the mandatory supplier list, and the new documented-procedure rules for medical device importers and distributors.

#Health Canada

By Mussarat Fatima

June 19, 2026 · Pharmaceuticals

Why 60-80% of FDA Warning Letters Still Cite Data Integrity in 2026

Data integrity appears in 60-80% of FDA drug GMP warning letters. See the 2026 findings, the ALCOA+ controls that prevent them, and how MFLRC supports gap assessments, audit-trail review, CSV, and CAPA.

#Data Integrity

By Mussarat Fatima

June 18, 2026 · Quality Assurance

How to Write SOPs That Pass a Health Canada Inspection

A practical, cross-sector guide to writing Health Canada SOPs for cannabis, drugs, NHPs, medical devices and food, with the ALCOA+ standard, common findings and an inspection-ready checklist.

#Health Canada

By Mussarat Fatima

June 18, 2026 · Medical Device

Canada's New MDEL Rules (In Force December 2026): What Importers and Distributors Must Do Now

Canada's Phase II MDEL amendments (SOR/2026-110) take effect December 14, 2026. Foreign distributors selling through a licensed Canadian importer no longer need their own MDEL, while supplier lists and documented procedures become mandatory. Here is what importers and distributors must do now.

#Medical Devices

By Mussarat Fatima

June 18, 2026 · Compliance

EU-GMP Certification for Cannabis: How and Why Canadian Producers Get Certified

EU-GMP certification is the key that unlocks Europe for Canadian cannabis producers. This 2026 guide covers the certification process, GACP, GMP and GDP, timelines, a compliance checklist and the most common mistakes to avoid.

#EU-GMP

By Mussarat Fatima

June 17, 2026 · Quality Assurance

Why Compliant Sites Still Fail Annex 1: Building an Inspection-Ready Contamination Control Strategy

Fully documented sterile sites still fail Annex 1 because they cannot show continuous, connected contamination control. Here is how to build an inspection-ready CCS.

#Pharmaceuticals

By Mussarat Fatima

June 16, 2026 · Good Production Practices

Cannabis Edibles vs Extracts: Classification Under the Cannabis Act

Edible cannabis and cannabis extracts look similar but face very different rules. Learn how Health Canada classifies ingestible cannabis products, the 10 mg and 1,000 mg THC limits, the food-format test, and how to stay compliant.

#Cannabis

By Mussarat Fatima

June 16, 2026 · Compliance

Top 5 Cannabis Compliance Mistakes (and How to Avoid Them)

Health Canada conducted 889 cannabis inspections in 2024-2025, and the same compliance gaps keep showing up. Learn the top five mistakes licensed producers make, what current inspection data reveals, and the practical fixes that keep you inspection-ready.

#Cannabis

By Mussarat Fatima

June 16, 2026 · Regulatory Affairs

EU GMP Annex 22, Annex 11 and Chapter 4: AI Rules for 2026

The European Commission, EMA and PIC/S published draft revisions of Annex 11 and Chapter 4 and a brand new Annex 22 on artificial intelligence on 7 July 2025. Finals are expected mid-2026. Here is what changes and how to get ready.

#Compliance

By Mussarat Fatima

June 15, 2026 · License

Cannabis Business Plan in Canada: A 2026 Founder's Guide

A cannabis business plan in Canada is not just an investor document. It is the blueprint that proves to Health Canada you can operate safely and legally. This 2026 guide covers licence classes, the CTLS, market data, the quality and compliance backbone, financials and the mistakes that sink applications.

#Cannabis

By Mussarat Fatima

June 15, 2026 · Food and Beverages

CFIA Is Inspecting 2,400 Food Facilities by Fall 2026: Is Your Preventive Control Plan Ready?

The CFIA will inspect more than 2,400 licensed-but-uninspected manufactured-food establishments by fall 2026. Here is what the expanded Preventive Control Plan, chemical hazard and food safety culture expectations mean for SFC licence-holders, and how to be inspection-ready.

#CFIA

By Mussarat Fatima

June 15, 2026 · Regulatory Affairs

FDA's First AI Warning Letter: What the Purolea Case Means for Your Quality Unit

The FDA's first warning letter to cite AI misuse (Purolea, 21 CFR 211.22(c)). What it means for your Quality Unit and how to govern AI in a GMP environment.

#Pharmaceuticals

By Mussarat Fatima

June 14, 2026 · Regulatory Affairs

How Canadian Cannabis Producers Win the German Market: A 2026 EU-GMP and GACP Certification Roadmap

Canadian producers supplied 53 percent of Germany medical cannabis imports in Q1 2026. This 2026 roadmap maps the EU-GMP and GACP certification path Canadian LPs need to reach the German pharmacy channel, from gap analysis to overseas inspection.

#Cannabis

By Mussarat Fatima

June 13, 2026 · Regulatory Affairs

DEA Schedule III Registration Window Closes June 22, 2026; Hearing Begins June 29

State-licensed U.S. medical marijuana operators must file for DEA registration by June 22, 2026 to keep operating, and the expedited Schedule III hearing runs June 29 to July 15. Here is what it means for U.S. operators and Canadian LPs.

#Controlled Substances

By Mussarat Fatima

June 13, 2026 · Natural Health Products

NHP GMP Guide GUI-0158 Version 4.0 Is Now in Force: A Compliance Checklist for Canadian Licence Holders

Health Canada's GUI-0158 Version 4.0 came into force March 4, 2026. A compliance checklist, QAP responsibility matrix, and FAQ for Canadian NHP licence holders and importers.

#GUI-0158

By Mussarat Fatima

June 12, 2026 · Regulatory Affairs

ICH E6(R3) Annex 2 Is Final: Decentralized Trial Compliance Before Canada's October 2026 Deadline

ICH E6(R3) Annex 2 was adopted at Step 4 on 3 June 2026, completing the modern GCP framework. Here is how Canadian sponsors and sites can get decentralized trial and real-world data compliance ready before Health Canada's 1 October 2026 deadline.

#Health Canada

By Mussarat Fatima

June 12, 2026 · Regulatory Affairs

Health Canada Terms and Conditions for Drugs: How Agile Licensing Replaces NOC/c by 2027

Health Canada's new terms and conditions framework takes effect April 1, 2027, replacing the NOC/c pathway. A practical guide to agile licensing and lifecycle obligations for sponsors.

#Health Canada

By Mussarat Fatima

June 11, 2026 · Regulatory Affairs

Health Canada's New Pre-Market Guidance for Machine Learning-Enabled Medical Devices: PCCP Explained

Health Canada's April 2026 pre-market guidance for machine learning-enabled medical devices introduces the Predetermined Change Control Plan (PCCP). Here is what Canadian manufacturers need to know about data quality, bias management and licensing.

#Health Canada

By Mussarat Fatima

June 11, 2026 · Regulatory Affairs

EU GMP Annex 11 Revision: Computerised Systems, Data Integrity and AI Rules Arriving in 2026

The biggest rewrite of EU GMP Annex 11 since 2011 lands mid-2026: 17 chapters covering validation, audit trails, supplier oversight, cybersecurity and a new Annex 22 on AI. Here is the gap assessment roadmap for Canadian exporters to the EU.

#Compliance

By Mussarat Fatima

June 10, 2026 · Regulatory Affairs

EU-GMP Chapter 4 Revision: When Photos, Video and Real-Time Feeds Become GMP Records

The revised EU-GMP Chapter 4 is format-neutral: photos, video and real-time feeds now count as GMP records. Learn what data-integrity controls your site needs before mid-2026.

#Pharmaceuticals

By Mussarat Fatima

June 9, 2026 · Regulatory Affairs

FDA's 2026 Pharmaceutical Quality Agenda: Distributed Manufacturing and AI/ML

The FDA's 2026 CDER agenda adds guidance on distributed manufacturing, AI/ML quality, PET drug CGMP, and Form 483 responses. Here is what Canadian exporters should do now.

#Pharmaceuticals

By Mussarat Fatima

June 8, 2026 · Regulatory Affairs

Psychedelic-Assisted Therapy in Canada: The 2025 Rules Explained

How psychedelic-assisted therapy is regulated in Canada in 2025: the three legal pathways (clinical trials, the Special Access Program, and Section 56 exemptions), the controlled-substance rules for psilocybin and MDMA, and what the Toth v. Canada Federal Court ruling means for practitioner training.

#Health Canada

By Mussarat Fatima

June 7, 2026 · Regulations

Industrial Hemp Regulations Reform: Health Canada's 2026 Consultation and What Hemp Growers Should Say Before June 30

Health Canada is consulting on major reforms to the Industrial Hemp Regulations, including possibly dropping licence requirements for some activities. Comments close June 30, 2026. Here is what is proposed, who benefits, and how to write a submission that gets read.

#Cannabis

By Mussarat Fatima

June 5, 2026 · Regulatory Affairs

Cosmetic Fragrance Allergen Disclosure and the 2026 Hotlist Update: A Reformulation Roadmap for Canadian Cosmetics Brands

From April 2026, Canadian cosmetics can no longer hide key fragrance allergens behind the word "parfum." A practical roadmap: what changed, how to read supplier allergen certificates, updating labels and CNFs, and what the 2026 Hotlist proposals mean for your formulas.

#Health Canada

By Mussarat Fatima

June 3, 2026 · Regulatory Affairs

EU GMP Annex 1 Contamination Control Strategy: The 2026 Exporter’s Guide

By 2026, EU GMP Annex 1 is fully in force and firmly enforced. Any Canadian pharmaceutical manufacturer or cannabis Licensed Producer exporting sterile or EU-GMP product to the EU or UK must have a documented, living Contamination Control Strategy (CCS) ready for inspection—or risk critical findings and loss of market access.

#Health Canada

By Mussarat Fatima

June 2, 2026 · Regulations

Cannabis Excise Tax Reform in Canada: The Expert Panel's Roadmap and What Could Change for LPs in 2026–2027

Cannabis excise tax reform in Canada is gaining momentum. The Expert Panel's final report urged a review of the $1/gram excise floor and potency-based duties, a 2025 Deloitte report sharpened the case, and micro-class limits have already quadrupled. Here's what could change for licensed producers and how to prepare.

#Cannabis

By Mussarat Fatima

June 1, 2026 · Regulatory Affairs

ICH E6(R3) Is Now in Force in Canada — Your Quality-by-Design and Risk-Proportionality Readiness Plan Before the 1 October 2026 Deadline

ICH E6(R3) Good Clinical Practice has been in force in Canada since 1 April 2026, with the transition period closing 30 September 2026. A verified quality-by-design and risk-proportionality readiness plan for sponsors, CROs, and sites.

#Health Canada

By Mussarat Fatima

May 24, 2026 · Regulatory Affairs

Are Exosome Skincare Products Cosmetics or Drugs in Canada? Health Canada's April 2026 Classification Notice, Decoded for Brands

Health Canada's April 2026 Final Notice (following its 14 August 2025 consultation Notice) clarifies how exosome, extracellular vesicle, and cell-conditioned media topical products are classified at the cosmetic-drug interface. Learn the three statutory considerations, MFLRC's six-trigger framework, the cosmetic/NHP/drug/biologic decision tree, and a reformulation checklist for skin-care, hair-care, and medi-aesthetic brands.

#Exosomes

By Mussarat Fatima

May 21, 2026 · Food and Beverages

Front-of-Package Nutrition Labelling Is Now Mandatory in Canada: What Every Food and Beverage Business Must Do Next

As of January 1, 2026, Health Canada’s Front-of-Package (FOP) nutrition symbol is mandatory on prepackaged foods and beverages that are high in saturated fat, sugars, or sodium. Learn what the new rules require, who must comply, key exemptions, and how to complete a defensible FOP readiness assessment for your full SKU portfolio.

#FOP Nutrition Labelling

By Mussarat Fatima

May 20, 2026 · Natural Health Products

NHP GMP Guide Version 4.0 (GUI-0158): What Natural Health Product Licence Holders Must Do Now

Health Canada's new NHP GMP Guide (GUI-0158, Version 4.0) came into force on March 4, 2026. It introduces real-time stability expectations, evidenced importer oversight, and a full quality-systems approach. Here is what Canadian NHP licence holders need to do now to stay inspection-ready.

#GUI-0158

By Mussarat Fatima

May 19, 2026 · Regulatory Affairs

What the New Controlled Substances Regulations (SOR/2025-242) Mean for Manufacturers and Dealers

A practical breakdown of SOR/2025-242 — Canada's new Controlled Substances Regulations. Monthly reporting, unified dealer licensing, October 1, 2026 deadline, and what manufacturers and dealers must do now.

#SOR/2025-242

By Mussarat Fatima

May 11, 2026 · Medical Device

EUDAMED Goes Mandatory May 28, 2026: A Practical Pre-Flight Checklist for MDEL Holders and EU Manufacturers

EUDAMED is no longer optional. From 28 May 2026, the first four modules become mandatory for every economic operator selling devices into the EU. Here's the pre-flight checklist MDEL holders and EU manufacturers should already be running.

#EUDAMED

By Mussarat Fatima

May 8, 2026 · Compliance

What DEA Schedule III Means for Canadian LPs — and Why Your Quality System Is Now a Sales Asset

The DEA's April 28 Schedule III order reshapes cross-border cannabis. Canadian LPs: here's what 280E elimination, M&A, and the June 27 deadline mean for your quality system — and your next capital raise.

#DEA, Schedule III, 280E, Canadian LP, Quality Systems, Cannabis M&A, Health Canada, GMP, Pharmaceutical Validation, Regulatory Affairs

By Mussarat Fatima

May 5, 2026 · Compliance

Cannabis Sampling Compliance in 2026: Health Canada Rules for Licensed Producers and Retailers

Learn how to comply with Health Canada’s 2026 cannabis sampling guidance, including storage, security, record-keeping, and provincial rules for retailer samples.

By Mussarat Fatima

March 29, 2026 · Regulations

Unlocking the Future: How New Canadian Regulations Are Revolutionizing the Landscape!

Discover how new cannabis regulations in Canada simplify compliance for licence holders, boost competition, and enhance the market—find out more!

By Mussarat Fatima

March 29, 2026 · Compliance

The Complete Guide to Obtaining a Cannabis License in Kentucky: Your Key to a Thriving Cannabis Business

Learn how cannabis licensing consultants can help Canadian cannabis businesses streamline compliance with expert knowledge, comprehensive SOPs, audits, tracking and reporting systems, and more. Get insights from industry experts and stay ahead of changing regulations.

By Mussarat Fatima

March 19, 2026 · Cannabis regulations, label, Quality assurance,

Health Canada Cannabis Regulation Changes 2026: What Every Licence Holder Must Know

By Mussarat Fatima

December 8, 2025 · Good Production Practices

Good Production Practices (GPP) for Cannabis in Canada

Good Production Practices (GPP) are the legal foundation of every federal cannabis licence in Canada. This guide explains the Part 5 requirements, the QAP role, GPP versus EU-GMP, and how to stay inspection-ready.

#Good Production Practices

By Mussarat Fatima

October 10, 2025 · Compliance

5 Ways Of Handling Food For Safety

By Mussarat Fatima

October 9, 2025 · Compliance

10 Importance Of Food Safety

By Mussarat Fatima

October 7, 2025 · Compliance

What Is Food Safety Services

By Mussarat Fatima

October 3, 2025 · Compliance

Importance Of Quality Assurance In Pharmaceutical Industry

By Mussarat Fatima

September 30, 2025 · Compliance

Starting Your First Grow: When to Trim Your Cannabis for Best Results

A first grower's guide to trimming cannabis at the right time, from vegetative pruning to post-harvest, with the compliance steps licensed producers need.

#Cannabis

By Mussarat Fatima

September 26, 2025 · Compliance

Quality Assurance Vs Compliance In Healthcare

By Mussarat Fatima

September 23, 2025 · Compliance

What Are The Four Types Of Quality Assurance?

By Mussarat Fatima

September 19, 2025 · Compliance

What Is The Meaning Of Compliance In Quality Assurance?

By Mussarat Fatima

September 16, 2025 · Compliance

How Effective Are The NHP Regulations

By Mussarat Fatima

September 12, 2025 · Good Production Practices

How To Get Budtender License Ontario

By Mussarat Fatima

August 28, 2025 · Compliance

Common Compliance Mistakes After Receiving A Cannabis License

By Mussarat Fatima

August 25, 2025 · Compliance

Post-Licensing Support: Why It’s Critical For Cannabis Businesses

By Mussarat Fatima

August 22, 2025 · GMP

How Often Do Cannabis Companies Get Audited?

By Mussarat Fatima

August 19, 2025 · Compliance

Natural health product license vs. cannabis license: key differences

By Mussarat Fatima

August 16, 2025 · Compliance

Overview of provincial cannabis licenses across Canada

By Mussarat Fatima

August 13, 2025 · Compliance

Cannabis Sales License: Costs, Timelines And Compliance Tips

By Mussarat Fatima

August 12, 2025 · Compliance

How Regulatory Consultants Handle License Renewals And Amendments

By Mussarat Fatima

August 12, 2025 · Compliance

How to Open a Retail Cannabis Dispensary: A Complete Guide

By Mussarat Fatima

August 12, 2025 · Compliance

Health Canada’s 2025 CBD Proposal: Big Changes Coming

By Mussarat Fatima

August 12, 2025 · Compliance

How to Decide Between Standard and Micro Processing Licences

By Mussarat Fatima

August 12, 2025 · Compliance

How to Advertise Your Cannabis Business in 2025

By Mussarat Fatima

August 12, 2025 · Compliance

Cannabis Cultivation: What a Cannabis Cultivator should know

By Mussarat Fatima

August 12, 2025 · GMP

Weed and Antibiotics: Is it Safe?

By Mussarat Fatima

August 12, 2025 · GMP

How To Get A Weed License In Ontario​

By Mussarat Fatima

August 12, 2025 · GMP

EU-GMP Vs. GPP: Choosing The Right Compliance Standard

By Mussarat Fatima

August 12, 2025 · GMP

How to Apply for a Liquor Retail Licence?

By Mussarat Fatima

August 12, 2025 · Regulations

How does farmgate licensing benefit small growers?

By Mussarat Fatima

August 10, 2025 · GMP

Will Trump federally legalize weed?

By Mussarat Fatima

August 7, 2025 · GMP

What is a dossier?

By Mussarat Fatima

August 4, 2025 · GMP

2026 Cannabis Reform Ballot (July 2025 Update)

By Mussarat Fatima

August 1, 2025 · GMP

Why Trump’s Cannabis Reform Is a Game Changer for The Cannabis Industry?

By Mussarat Fatima

June 30, 2025 · GMP

how to apply for a cannabis processing license in Canada

By Mussarat Fatima

June 27, 2025 · GMP

what is a USA cannabis license and how to get it

By Mussarat Fatima

June 24, 2025 · GMP

Cannabis cultivation license requirements Canada

By Mussarat Fatima

June 21, 2025 · GMP

How to sell cannabis legally in Canada?

By Mussarat Fatima

June 18, 2025 · GMP

Farmgate vs retail cannabis license differences

By Mussarat Fatima

June 15, 2025 · GMP

Cannabis analytical testing lab setup guide

By Mussarat Fatima

June 12, 2025 · GMP

Cannabis QA compliance checklist

By Mussarat Fatima

June 9, 2025 · GMP

Differences in provincial cannabis licenses

By Mussarat Fatima

June 6, 2025 · GMP

Mistakes to avoid in cannabis license applications

By Mussarat Fatima

June 3, 2025 · Compliance

How to Pass a Cannabis Regulatory Audit: A Complete Guide

A Health Canada inspection rewards everyday discipline, not last-minute cramming. Here is what inspectors check, the findings that trip producers up, and how to stay audit-ready every day.

#Cannabis

By Mussarat Fatima

September 25, 2024 · GMP

GMP Certification for Cannabis: A Complete Guide for Producers

In Canada, cannabis producers follow Good Production Practices, while EU-GMP certification unlocks export markets like Germany. Here is what GMP certification involves, what it costs, and how to prepare.

#Cannabis

By Mussarat Fatima

July 2, 2024 · Cannabis regulations, label, Quality assurance,

Opening a dispensary in Canada | Cannabis Legalisation

By Mussarat Fatima

June 10, 2024 · Compliance

Enhancing Hygiene in Cannabis Production: GMP Cleaning for Braided Stainless-Steel Cables

Unlock the secrets of superior cannabis production hygiene with our latest blog post. Dive into GMP's rigorous cleaning protocols for braided stainless-steel cables, guaranteeing unparalleled quality and safety in every cannabis product. Elevate your industry knowledge and stay ahead of the curve today!

By Mussarat Fatima

December 19, 2023 · License

Cannabis Research Licence in Canada: A Step-by-Step Guide

A cannabis research licence is how universities, companies and clinicians legally study cannabis in Canada. This guide explains the licence types, the CTLS application process, NTRC and clinical-trial rules, and how to build an approvable file.

#Cannabis Research

By Mussarat Fatima

December 4, 2023 · Compliance

The Ultimate Guide to Getting Your Cannabis Micro License for Cultivation and Processing"

By Mussarat Fatima

November 27, 2023 · License

The Complete Guide To Obtaining Dispensary and Retail Licences In The Cannabis Industry

By Mussarat Fatima

October 17, 2023 · Cultivation

Five Years of Cannabis Legalization in Canada: A Comprehensive Review of Progress and Challenges

Five years after Canada legalized cannabis in October 2018, we review the achievements and the ongoing challenges, from economic growth and public health to youth use, impaired driving and pricing.

#Cannabis

By Mussarat Fatima

March 23, 2023 · Compliance

Cannabis Quality Assurance in Canada: The Risks of Ignoring QA

Quality assurance is not optional for Canadian cannabis licence holders. Here is what QA involves under current Health Canada rules, the real risks of cutting corners, and a practical compliance checklist.

#Cannabis

By Mussarat Fatima

October 5, 2022 · Good Production Practices

Root Cause Analysis in Cannabis and GMP: 11 Mistakes to Avoid

Root cause analysis drives effective CAPA. Learn the 11 mistakes that make investigations fail in cannabis and GMP facilities, and how to avoid each one.

#Cannabis

By Mussarat Fatima

September 9, 2022 · Good Production Practices

Cannabis Product Recalls in Canada: 9 Ways to Avoid Them

Cannabis recalls are preventable quality failures. Here are nine practical ways to avoid them, plus Health Canada recall types, timelines, and mock recall rules.

#Cannabis

By Mussarat Fatima

September 9, 2022 · License

How to Open and Operate a Cannabis Retail Store or Farmgate in Ontario

A practical, up to date guide to opening and operating a cannabis retail store or farmgate in Ontario, covering AGCO licences, OCS wholesale, store rules, fees, staff training and the compliance habits that keep your authorization in good standing.

#Cannabis

By Mussarat Fatima

September 8, 2022 · Compliance

Cannabis Compliance in Canada: 10 Essentials to Succeed

Ten practical essentials for cannabis compliance in Canada, from building a compliance team and internal audits to marketing rules, provincial age limits and recordkeeping.

#Cannabis

By Mussarat Fatima

September 8, 2022 · Compliance

Internal Audits for Cannabis and GMP Facilities: A Complete Guide

Internal audits help Canadian cannabis, pharma and NHP producers find and fix compliance gaps before Health Canada does. Learn the process, checklist and best practices.

#Cannabis

By Mussarat Fatima